Intra-Cellular Therapies Inc. Stock Forecast

Intra-Cellular Therapies Inc. stock downgraded to Hold/Accumulate
(Updated on Apr 26, 2024)

ITCI Signals & Forecast

The Intra-Cellular Therapies Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $73.06 and $68.84. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 16, 2024, and so far it has fallen -8.24%. Further fall is indicated until a new bottom pivot has been found. The stock had a Golden Star Signal on Friday, April 05, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Intra-Cellular Therapies Inc. stock

Intra-Cellular Therapies Inc. finds support from accumulated volume at $72.37 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.86 between high and low, or 2.60%. For the last week, the stock has had daily average volatility of 3.11%.

Our recommended stop-loss: $69.36 (-5.32%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 8 days ago.)

Trading Expectations (ITCI) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Intra-Cellular Therapies Inc. to open at $72.81, and during the day (based on 14 day Average True Range), to move between $69.90 and $76.62, which gives a possible trading interval of +/-$3.36 (+/-4.58%) up or down from last closing price. If Intra-Cellular Therapies Inc. takes out the full calculated possible swing range there will be an estimated 9.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $72.37 (1.21%) than the resistance at $74.54 (1.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Intra-Cellular Therapies Inc. stock A Buy?

Intra-Cellular Therapies Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: -0.541 Hold/Accumulate Downgraded

Predicted Opening Price for Intra-Cellular Therapies Inc. of Monday, April 29, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.